Gilead Sciences (GILD) Other Working Capital Changes (2009 - 2026)

Gilead Sciences (GILD) has reported Other Working Capital Changes for 18 consecutive years, with -$5.0 million the latest figure, recorded in Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$5.0 million, up 58.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $318.0 million (up 51.43% YoY), and the FY2025 annual result was $311.0 million, up 20.08% from the prior year.
• Other Working Capital Changes was -$5.0 million for Q1 2026 at Gilead Sciences, down from $36.0 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $368.0 million in Q3 2025 and troughed at -$81.0 million in Q2 2025.
• Average Other Working Capital Changes over 5 years is $38.8 million, with a median of $27.0 million recorded in 2022.
• Year-over-year, Other Working Capital Changes jumped 1240.0% in 2024 and sank 526.32% in 2025.
• Over 5 years, Other Working Capital Changes stood at $65.0 million in 2022, then plunged by 50.77% to $32.0 million in 2023, then jumped by 356.25% to $146.0 million in 2024, then slumped by 75.34% to $36.0 million in 2025, then sank by 113.89% to -$5.0 million in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$5.0 million in Q1 2026, $36.0 million in Q4 2025, and $368.0 million in Q3 2025.